192 related articles for article (PubMed ID: 19235594)
1. Strategies to decrease taxanes toxicities in the adjuvant treatment of early breast cancer.
Tang SC
Cancer Invest; 2009 Feb; 27(2):206-14. PubMed ID: 19235594
[TBL] [Abstract][Full Text] [Related]
2. Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.
Tang SC
Cancer Invest; 2009 Jun; 27(5):489-95. PubMed ID: 19479486
[TBL] [Abstract][Full Text] [Related]
3. Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti FR; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso SI; Lopez M
Clin Ter; 2008; 159(6):453-6. PubMed ID: 19169608
[TBL] [Abstract][Full Text] [Related]
4. Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: a meta-analysis of phase III randomized control trials.
Shao N; Wang S; Yao C; Xu X; Zhang Y; Zhang Y; Lin Y
Breast; 2012 Jun; 21(3):389-93. PubMed ID: 22542064
[TBL] [Abstract][Full Text] [Related]
5. Do anthracyclines still have a role in adjuvant chemotherapy of breast cancer?
Davidson A; Gelmon K
Future Oncol; 2011 Jan; 7(1):37-55. PubMed ID: 21174537
[TBL] [Abstract][Full Text] [Related]
6. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
Piccart-Gebhart MJ; Burzykowski T; Buyse M; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
J Clin Oncol; 2008 Apr; 26(12):1980-6. PubMed ID: 18421049
[TBL] [Abstract][Full Text] [Related]
7. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
Herceg D; Vrbanec D
Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials.
Estévez LG; Muñoz M; Alvarez I; Fernández Y; García-Mata J; Ruiz-Borrego M; Tusquets I; Seguí MA; Rodríguez-Lescure A; Adrover E; Lluch A
Cancer Treat Rev; 2007 Aug; 33(5):474-83. PubMed ID: 17561350
[TBL] [Abstract][Full Text] [Related]
9. Survival data of patients with anthracycline- or taxane-pretreated or resistant metastatic breast cancer.
Barnett CM
Pharmacotherapy; 2009 Dec; 29(12):1482-90. PubMed ID: 19947807
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.
Dang C; Hudis C
Clin Breast Cancer; 2006 Apr; 7(1):51-8. PubMed ID: 16764744
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic breast cancer: looking towards the future.
Amar S; Roy V; Perez EA
Breast Cancer Res Treat; 2009 Apr; 114(3):413-22. PubMed ID: 18465221
[TBL] [Abstract][Full Text] [Related]
12. Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.
Gianni L; Salvatorelli E; Minotti G
Cardiovasc Toxicol; 2007; 7(2):67-71. PubMed ID: 17652806
[TBL] [Abstract][Full Text] [Related]
13. The role of anthracyclines in the treatment of early breast cancer.
Greene J; Hennessy B
J Oncol Pharm Pract; 2015 Jun; 21(3):201-12. PubMed ID: 24769570
[TBL] [Abstract][Full Text] [Related]
14. Combined anthracycline-taxane regimens in the adjuvant setting.
Mamounas EP; Sledge GW
Semin Oncol; 2001 Aug; 28(4 Suppl 12):24-31. PubMed ID: 11552227
[TBL] [Abstract][Full Text] [Related]
15. A review of vinorelbine in the treatment of breast cancer.
Domenech GH; Vogel CL
Clin Breast Cancer; 2001 Jul; 2(2):113-28. PubMed ID: 11899783
[TBL] [Abstract][Full Text] [Related]
16. Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma.
Bria E; Giannarelli D; Felici A; Peters WP; Nisticò C; Vanni B; Cuppone F; Cognetti F; Terzoli E
Cancer; 2005 Feb; 103(4):672-9. PubMed ID: 15637696
[TBL] [Abstract][Full Text] [Related]
17. [Medical treatment of early breast cancer: chemotherapy].
Ejlertsen B; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
[TBL] [Abstract][Full Text] [Related]
18. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
Halterman PA
Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
[TBL] [Abstract][Full Text] [Related]
19. [Role of adjuvant chemotherapy in the choice of chemotherapeutic treatment of metastatic breast cancer].
Lopez M; Di Lauro L; Viola G; Conti F; Foggi P; Vici P
Clin Ter; 2009; 160(6):489-97. PubMed ID: 20198293
[TBL] [Abstract][Full Text] [Related]
20. Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes.
Rivera E
Am J Clin Oncol; 2010 Apr; 33(2):176-85. PubMed ID: 19675449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
